
GeoVax Secures Funding Through Warrant Transaction to Advance Vaccine and Cancer Therapy Programs
GeoVax Labs has entered into a warrant inducement agreement that will provide approximately $863,000 in immediate funding to support its clinical-stage vaccine and immunotherapy development programs targeting infectious diseases and cancer.
Read full story



























